Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1375983

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1375983

Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Market Analysis By Product (Topical Hemostat, Adhesive & Tissue Sealant), By Region (Europe, APAC, North America), And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Hemostasis And Tissue Sealing Agents Market Growth & Trends:

The global hemostasis and tissue sealing agents market size is expected to reach USD 14.47 billion by 2030, registering a CAGR of 8.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The agents have gained popularity over time due to their ability to prevent blood loss. The rapid growth of minimally invasive technology and the demand for faster recovery by patients are expected to promote market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of the American population are currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times.

An estimate over the rising incidence was made by the CDC, which concluded that over 48% of the entire American population is expected to suffer from chronic conditions. The market is expected to witness lucrative growth over the next seven years owing to an increase in product demand supported by the rising surgery volumes. Growth in the geriatric population and the prevalence of chronic conditions are also among the key factors driving the market. In December 2019, the Ethicon, a unit of Johnson & Johnson, launched its protein spray for blood-stopping, designed to quickly & efficiently control and seal off excessive bleeding during minimally invasive procedures and open surgeries.

During the COVID-19 pandemic, severe cases among patients infected by the virus have shown the tendency to develop septic shock and Acute Respiratory Distress Syndrome (ARDS), demanding special care in ICU, with residual chronic disability and poor long-term results. Among these patients in the ICU, Coagulopathy has been commonly noticed indicating underlying diseases and organ dysfunction. This has been one of the major contributing factors to the increasing demand for hemostasis & tissue sealing products.

Hemostasis And Tissue Sealing Agents Market Report Highlights:

  • The market growth can be attributed to a rise in the global volume of surgeries and the applicability of the product across a variety of surgeries to avoid the occurrence of hypovolemic shock, thrombocytopenia, blood transfusions, and postoperative complications
  • The topical hemostat segment accounted for the largest revenue share of 67.2% in 2022. In addition, a segment is expected to grow at the fastest CAGR of 9.2% during the forecast period due to its use with conventional treatment to provide cost-efficiency, quick & easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity.
  • The adhesive & tissue sealant segment is expected to grow at a CAGR of 8.1% over the forecast period. Adhesives and tissue sealants are crucial in controlling blood loss during surgical procedures and function by binding with and sealing the damaged tissues.
  • North America dominated the market and accounted for the largest revenue share of 33.1% in 2022, owing to the growing prevalence of cardiovascular disorders, diabetes, and cancer within the region.
Show more
Product Code: 978-1-68038-597-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Material outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis & Tissue Sealing Agents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Hemostasis & Tissue Sealing Agents Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Hemostasis & Tissue Sealing Agents Market: Product Estimates & Trend Analysis

  • 4.1. Hemostasis & Tissue Sealing Agents Market: Key Takeaways
  • 4.2. Hemostasis & Tissue Sealing Agents Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Topical Hemostat
    • 4.3.1. Topical Hemostat market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.1. Active market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.2.2. Mechanical market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.2.3 Flowable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Adhesive & Tissue Sealant
    • 4.4.1. Adhesive & tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Synthetic tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Natural tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Adhesion barrier products market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hemostasis & Tissue Sealing Agents Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Hemostasis & Tissue Sealing Agents Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. U.K.
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Johnson & Johnson
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Artivion, Inc
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Pfizer
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. C R Bard
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. B Braun
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Covidien
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Advance Medical Solutions Group
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Smith & Nephew
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
Show more
Product Code: 978-1-68038-597-7

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 10 France hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 18 China hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 20 India hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hemostasis & tissue sealing agents: Market outlook
  • Fig. 9 Hemostasis & tissue sealing agents: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Hemostasis & tissue sealing agents market driver impact
  • Fig. 15 Hemostasis & tissue sealing agents market restraint impact
  • Fig. 16 Hemostasis & Tissue Sealing Agents Market Strategic Initiatives Analysis
  • Fig. 17 Hemostasis & tissue sealing agents market: Product movement analysis
  • Fig. 18 Hemostasis & tissue sealing agents market: Product outlook and key takeaways
  • Fig. 19 Topical hemostat market estimates and forecasts, 2018 - 2030
  • Fig. 20 Active market estimates and forecasts, 2018 - 2030
  • Fig. 21 Mechanical market estimates and forecasts, 2018 - 2030
  • Fig. 22 Flowable market estimates and forecasts, 2018 - 2030
  • Fig. 23 Adhesives & tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 24 Synthetic tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 25 Natural tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 26 Adhesion barrier products market estimates and forecasts, 2018 - 2030
  • Fig. 27 Global Hemostasis & tissue sealing agents market: Regional movement analysis
  • Fig. 28 Global Hemostasis & tissue sealing agents market: Regional outlook and key takeaways
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030
  • Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 31 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 33 U.K. market estimates and forecasts, 2018 - 2030
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 35 France market estimates and forecasts, 2018 - 2030
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 43 China market estimates and forecasts, 2018 - 2030
  • Fig. 44 India market estimates and forecasts, 2018 - 2030
  • Fig. 45 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!